Product Images Gabapentin

This is a formula used to calculate the creatinine clearance rate of a patient, which is an important measure of kidney function. The formula takes into account the patient's age, weight, and serum creatinine level. It also includes an adjustment factor for female patients. The resulting value can help healthcare professionals determine if a patient has any kidney dysfunction, and adjust medication dosages accordingly.*

This appears to be a list of molecular formulas for organic compounds. The first formula, CH,NH, is not a valid molecular formula as it is missing information about the number of atoms. The second formula, CH,CO,H, represents acetic acid, a colorless liquid widely used in the production of a variety of industrial and consumer goods.*

This appears to be a table showing the mean pain score for a fixed dose period of 4 weeks, comparing a placebo group to two groups taking different doses of Gabapentin (1800mg/day and 2400mg/day). The pain score was recorded at baseline and at various time points during the 4-week period.*

The text includes a figure 3 showing the proportion of responders in controlled PHN studies with patients having more than a 50% reduction in pain score. There are two studies mentioned, Study 1 and Study 2. However, the percentages of responders in Study 1 are not provided. The figure also has some statistical markers such as "p < 0.001" and "#p< 00l" denoting significant differences in data. Lastly, the text includes the names of some drugs and their costs.*

This appears to be a label of a medication, possibly a generic version of Neurontin 800mg tablet, produced by Strides Pharma Science Limited. The medication is packaged by Bryant Ranck Prepack and expires at a certain month and year (MM/YY) as indicated on the label. The NDC (National Drug Code) number is also provided for identification. The storage condition for the medication is between 20°-25°C, with instructions to keep all drugs out of reach of children.*